Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

OBIO

Orchestra BioMed Holdings Inc

Sep 06 • 04:00PM ET

5.61

Dollar change -0.18
Percentage change -3.11	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI IWM VXF IWN SCHA VTWO IWO IWC SCHB RSSL

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.56	Insider Own	33.10%	Shs Outstand	35.78M	Perf Week	-16.02%
Market Cap	212.17M	Forward P/E	-	EPS next Y	-1.81	Insider Trans	-0.10%	Shs Float	25.31M	Perf Month	-3.77%
Income	-55.58M	PEG	-	EPS next Q	-0.43	Inst Own	47.96%	Short Float	4.19%	Perf Quarter	-29.79%
Sales	2.08M	P/S	102.00	EPS this Y	-12.97%	Inst Trans	-30.71%	Short Ratio	8.43	Perf Half Y	-13.56%
Book/sh	1.23	P/B	4.55	EPS next Y	-8.13%	ROA	-56.06%	Short Interest	1.06M	Perf Year	-16.52%
Cash/sh	1.72	P/C	3.26	EPS next 5Y	-	ROE	-83.22%	52W Range	4.22 - 11.69	Perf YTD	-38.55%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-122.88%	52W High	-52.01%	Beta	0.47
Dividend TTM	-	Quick Ratio	4.58	Sales past 5Y	-7.29%	Gross Margin	81.46%	52W Low	32.94%	ATR (14)	0.56
Dividend Ex-Date	-	Current Ratio	4.58	EPS Y/Y TTM	-78.78%	Oper. Margin	-2803.61%	RSI (14)	37.66	Volatility	7.87% 9.58%
Employees	56	Debt/Eq	0.03	Sales Y/Y TTM	0.00%	Profit Margin	-2673.26%	Recom	1.00	Target Price	15.60
Option/Short	No / Yes	LT Debt/Eq	0.02	EPS Q/Q	-28.28%	Payout	-	Rel Volume	0.29	Prev Close	5.79
Sales Surprise	-8.47%	EPS Surprise	-14.65%	Sales Q/Q	-14.97%	Earnings	Aug 12 AMC	Avg Volume	125.80K	Price	5.61
SMA20	-10.46%	SMA50	-20.58%	SMA200	-16.27%	Trades		Volume	36,179	Change	-3.11%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-22-24	Initiated	H.C. Wainwright	Buy	$14
Jul-25-24	Initiated	B. Riley Securities	Buy	$15
Jan-19-24	Initiated	Jefferies	Buy	$14
Feb-24-23	Initiated	Piper Sandler	Overweight	$15
Feb-07-23	Initiated	Chardan Capital Markets	Buy	$20

Aug-12-24 05:35PM	Orchestra BioMed Holdings, Inc. (OBIO) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:20PM	Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update (GlobeNewswire)
Aug-08-24 09:35AM	Orchestra BioMed Holdings, Inc. (OBIO) Loses -25.35% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks) +13.55%
Aug-01-24 10:01AM	Orchestra BioMed Holdings, Inc. (OBIO) Expected to Beat Earnings Estimates: Should You Buy? (Zacks) -7.18%
Jul-30-24 08:00AM	Orchestra BioMed Announces Appointment of Cardiovascular Device Industry Expert John Mack to Board of Directors (GlobeNewswire)
12:00PM	Loading…
Jul-26-24 12:00PM	Orchestra BioMed Holdings, Inc. (OBIO) Upgraded to Buy: Here's What You Should Know (Zacks) -6.70%
09:55AM	Wall Street Analysts Believe Orchestra BioMed Holdings, Inc. (OBIO) Could Rally 102.61%: Here's is How to Trade (Zacks)
Jul-23-24 09:00AM	Precision Neuroscience Expands Executive Team as Brain Computer Interface Industry Rapidly Advances (GlobeNewswire)
Jun-24-24 08:07AM	Orchestra BioMed Holdings, Inc. (OBIO) Stock Jumps 7.3%: Will It Continue to Soar? (Zacks) +9.02%
Jun-04-24 08:00AM	Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024 (GlobeNewswire) +10.64%
Jun-03-24 12:00PM	All You Need to Know About Orchestra BioMed Holdings, Inc. (OBIO) Rating Upgrade to Buy (Zacks)
09:55AM	Does Orchestra BioMed Holdings, Inc. (OBIO) Have the Potential to Rally 135.64% as Wall Street Analysts Expect? (Zacks)
May-22-24 08:43AM	Orchestra BioMed to Participate in Jefferies Global Healthcare Conference (GlobeNewswire)
May-13-24 09:53PM	OBIO Stock Earnings: Orchestra BioMed Hldgs Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace) +13.04%
06:05PM	Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:58PM	Loading…
04:58PM	Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update (GlobeNewswire)
Apr-30-24 08:30AM	Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Patents (GlobeNewswire)
08:00AM	Orchestra BioMed to Host In-Person R&D Day in New York on AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024 (GlobeNewswire)
Mar-27-24 04:17PM	Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update (GlobeNewswire)
Mar-26-24 08:00AM	Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of Directors (GlobeNewswire) +5.20%
Mar-13-24 08:00AM	Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting (GlobeNewswire)
Mar-07-24 08:00AM	Orchestra BioMed to Participate in Upcoming Investor Conferences (GlobeNewswire) -6.62%
Mar-06-24 08:37AM	Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemodynamic Effects of AVIM Therapy In Hypertensive Pacemaker Patients (GlobeNewswire)
Feb-26-24 08:00AM	Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambulatory Systolic Blood Pressure in Hypertensive Pacemaker Patients Treated with AVIM Therapy for Over 3 Years (GlobeNewswire)
Feb-16-24 09:13AM	Why Orchestra BioMed (OBIO) Might Surprise This Earnings Season (Zacks) -8.45%
Jan-08-24 07:30AM	Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients (GlobeNewswire) +9.38%
Nov-13-23 04:21PM	Orchestra BioMed Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire) +14.61% +13.08%
Nov-09-23 04:42PM	Orchestra BioMed to Present at Upcoming Investor Conferences (GlobeNewswire)
Oct-30-23 03:52PM	Billionaire Marc Lasrys Top 10 Stock Picks (Insider Monkey)
Sep-22-23 11:27AM	Lab Notes: Main Line firm spins off company that will focus on OTC product pipeline (American City Business Journals)
02:37PM	Loading…
Sep-19-23 02:37PM	Rebel's Edge - September 19: $NIO, $BHC, $OBIO, and the Firing of MSU's Football Coach (TheStreet.com) +27.61%
07:30AM	Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT for the Treatment of Hypertension in Pacemaker Patients (GlobeNewswire)
Sep-06-23 05:00PM	Motus GI Appoints Medical Device Industry Veteran Scott Durbin to its Board of Directors (GlobeNewswire) -7.74%
Aug-10-23 04:34PM	Orchestra BioMed Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire) +7.05%
Aug-08-23 08:30AM	Orchestra BioMed Granted FDA Approval of IDE for U.S. Pivotal Study of Virtue® Sirolimus AngioInfusion Balloon in Patients with Coronary In-Stent Restenosis (GlobeNewswire)
Jul-27-23 09:47AM	Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) stock most popular amongst retail investors who own 36%, while hedge funds hold 28% (Simply Wall St.) -14.00%
Jun-28-23 02:16PM	Why Shares of Orchestra BioMed Holdings Jumped Wednesday (Motley Fool) +24.85%
Jun-26-23 08:00AM	Orchestra BioMed Set to Join Russell 3000® and other FTSE Russell Indexes (GlobeNewswire) -9.81%
Jun-07-23 08:30AM	Orchestra BioMed Appoints Bill Little as Executive Vice President of Corporate Development and Strategy and Andrew Taylor as Chief Financial Officer (GlobeNewswire) -6.42%
Jun-01-23 08:00AM	Orchestra BioMed to Present at the Jefferies Global Healthcare Conference (GlobeNewswire) +8.93%
May-12-23 09:15AM	Orchestra BioMed Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Apr-11-23 05:39AM	3 Stocks That Already Doubled in 2023 and Could Keep Climbing (Motley Fool) +10.12%
Mar-27-23 06:05AM	Orchestra BioMed Holdings Full Year 2022 Earnings: US$14.60 loss per share (vs US$10.90 loss in FY 2021) (Simply Wall St.)
Mar-24-23 03:52PM	Why Shares of Orchestra BioMed Jumped This Week (Motley Fool)
Mar-07-23 08:00AM	Orchestra BioMed to Present at Upcoming Investor Conferences (GlobeNewswire) -6.77%
Feb-24-23 08:00AM	Orchestra BioMed Announces Upcoming Presentations on BackBeat CNT and Virtue® SAB at CRT 2023 (GlobeNewswire)
Feb-07-23 08:00AM	Orchestra BioMed Strengthens Senior Leadership Team (GlobeNewswire)

Orchestra Biomed Holdings, Inc. engages in the provision of biomedical technologies to patients through risk-reward-sharing partnerships with medical device companies. The company was founded on May 25, 2020 and is headquartered in New Hope, PA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sherman Darren	See Remarks	Sep 04 '24	Sale	6.10	6,837	41,706	793,275	Sep 06 07:31 PM
Sherman Darren	See Remarks	Sep 05 '24	Sale	5.85	6,961	40,722	786,314	Sep 06 07:31 PM
Sherman Darren	See Remarks	Sep 06 '24	Sale	5.65	6,819	38,527	779,495	Sep 06 07:31 PM
Sherman Darren	Officer	Sep 06 '24	Proposed Sale	5.65	6,819	38,513		Sep 06 04:20 PM
Fain Eric S	Director	Sep 06 '24	Proposed Sale	5.64	2,000	11,279		Sep 06 04:13 PM
Sherman Darren	Officer	Sep 05 '24	Proposed Sale	5.85	6,961	40,709		Sep 05 04:30 PM
Sherman Darren	Officer	Sep 04 '24	Proposed Sale	6.10	6,837	41,702		Sep 04 04:10 PM
Hochman David P	See Remarks	Aug 14 '24	Buy	5.84	2,500	14,600	567,998	Aug 15 05:30 PM
Hochman David P	See Remarks	Jun 25 '24	Buy	6.95	1,000	6,950	333,502	Jun 26 04:15 PM
Little William Reed	See Remarks	May 30 '24	Buy	7.00	4,000	28,000	307,859	Jun 03 04:15 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

OBIO

Orchestra BioMed Holdings Inc

Upgrade your FINVIZ experience